Barclays’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Buy |
451,080
+177,265
| +65% | +$9.74M | 0.01% | 732 |
|
|
2025
Q1 | $19.4M | Sell |
273,815
-55,051
| -17% | -$3.89M | 0.01% | 754 |
|
|
2024
Q4 | $21.6M | Buy |
328,866
+41,275
| +14% | +$2.71M | 0.01% | 750 |
|
|
2024
Q3 | $20.2M | Sell |
287,591
-830,789
| -74% | -$58.4M | 0.01% | 745 |
|
|
2024
Q2 | $92.1M | Sell |
1,118,380
-4,136,140
| -79% | -$341M | 0.03% | 340 |
|
|
2024
Q1 | $459M | Sell |
5,254,520
-34,373
| -0.6% | -$3M | 0.16% | 96 |
|
|
2023
Q4 | $510M | Sell |
5,288,893
-284,264
| -5% | -$27.4M | 0.19% | 73 |
|
|
2023
Q3 | $493M | Buy |
5,573,157
+2,911,886
| +109% | +$258M | 0.31% | 57 |
|
|
2023
Q2 | $231M | Buy |
2,661,271
+1,056,445
| +66% | +$91.6M | 0.15% | 136 |
|
|
2023
Q1 | $156M | Sell |
1,604,826
-377,663
| -19% | -$36.7M | 0.07% | 137 |
|
|
2022
Q4 | $205M | Sell |
1,982,489
-270,314
| -12% | -$28M | 0.09% | 129 |
|
|
2022
Q3 | $191M | Buy |
2,252,803
+87,163
| +4% | +$7.39M | 0.21% | 103 |
|
|
2022
Q2 | $179M | Buy |
2,165,640
+2,001,395
| +1,219% | +$166M | 0.11% | 115 |
|
|
2022
Q1 | $12.7M | Sell |
164,245
-34,114
| -17% | -$2.63M | 0.01% | 802 |
|
|
2021
Q4 | $17.5M | Sell |
198,359
-10,771
| -5% | -$952K | 0.01% | 711 |
|
|
2021
Q3 | $16.2M | Buy |
209,130
+15,055
| +8% | +$1.16M | 0.01% | 755 |
|
|
2021
Q2 | $16.2M | Buy |
194,075
+9,219
| +5% | +$769K | 0.01% | 758 |
|
|
2021
Q1 | $14M | Sell |
184,856
-94,798
| -34% | -$7.16M | 0.01% | 728 |
|
|
2020
Q4 | $24.5M | Buy |
279,654
+56,826
| +26% | +$4.98M | 0.01% | 510 |
|
|
2020
Q3 | $17M | Sell |
222,828
-62,955
| -22% | -$4.79M | 0.01% | 564 |
|
|
2020
Q2 | $35.3M | Sell |
285,783
-13,284
| -4% | -$1.64M | 0.03% | 300 |
|
|
2020
Q1 | $25.3M | Sell |
299,067
-103,556
| -26% | -$8.75M | 0.02% | 339 |
|
|
2019
Q4 | $34M | Buy |
402,623
+170,459
| +73% | +$14.4M | 0.02% | 450 |
|
|
2019
Q3 | $15.6M | Sell |
232,164
-185,826
| -44% | -$12.5M | 0.01% | 630 |
|
|
2019
Q2 | $35.8M | Buy |
417,990
+129,797
| +45% | +$11.1M | 0.02% | 420 |
|
|
2019
Q1 | $25.6M | Buy |
288,193
+32,717
| +13% | +$2.91M | 0.02% | 455 |
|
|
2018
Q4 | $21.8M | Sell |
255,476
-134,679
| -35% | -$11.5M | 0.02% | 450 |
|
|
2018
Q3 | $37.8M | Sell |
390,155
-105,106
| -21% | -$10.2M | 0.03% | 354 |
|
|
2018
Q2 | $46.7M | Buy |
495,261
+132,231
| +36% | +$12.5M | 0.04% | 263 |
|
|
2018
Q1 | $29.4M | Buy |
363,030
+7,445
| +2% | +$604K | 0.02% | 444 |
|
|
2017
Q4 | $31.7M | Buy |
355,585
+27,936
| +9% | +$2.49M | 0.03% | 364 |
|
|
2017
Q3 | $30.5M | Buy |
327,649
+9,857
| +3% | +$917K | 0.03% | 285 |
|
|
2017
Q2 | $28.9M | Buy |
317,792
+21,100
| +7% | +$1.92M | 0.03% | 265 |
|
|
2017
Q1 | $26M | Sell |
296,692
-7,632
| -3% | -$670K | 0.03% | 278 |
|
|
2016
Q4 | $25.2M | Buy |
304,324
+49,080
| +19% | +$4.07M | 0.03% | 274 |
|
|
2016
Q3 | $23.6M | Buy |
255,244
+35,012
| +16% | +$3.24M | 0.03% | 256 |
|
|
2016
Q2 | $17.1M | Sell |
220,232
-15,366
| -7% | -$1.2M | 0.02% | 323 |
|
|
2016
Q1 | $19.3M | Sell |
235,598
-21,540
| -8% | -$1.77M | 0.03% | 287 |
|
|
2015
Q4 | $26.7M | Sell |
257,138
-156,055
| -38% | -$16.2M | 0.03% | 246 |
|
|
2015
Q3 | $43.4M | Buy |
413,193
+241,852
| +141% | +$25.4M | 0.05% | 158 |
|
|
2015
Q2 | $23.3M | Buy |
171,341
+15,909
| +10% | +$2.16M | 0.03% | 319 |
|
|
2015
Q1 | $19.3M | Sell |
155,432
-108,411
| -41% | -$13.4M | 0.02% | 430 |
|
|
2014
Q4 | $23.7M | Sell |
263,843
-36,478
| -12% | -$3.28M | 0.02% | 364 |
|
|
2014
Q3 | $21.6M | Buy |
300,321
+34,851
| +13% | +$2.51M | 0.02% | 376 |
|
|
2014
Q2 | $16.5M | Buy |
265,470
+20,666
| +8% | +$1.28M | 0.02% | 445 |
|
|
2014
Q1 | $16.6M | Sell |
244,804
-362,562
| -60% | -$24.7M | 0.02% | 474 |
|
|
2013
Q4 | $42.5M | Buy |
607,366
+328,943
| +118% | +$23M | 0.04% | 228 |
|
|
2013
Q3 | $20M | Buy |
278,423
+126,947
| +84% | +$9.14M | 0.02% | 358 |
|
|
2013
Q2 | $8.44M | Buy |
+151,476
| New | +$8.44M | 0.01% | 633 |
|